HS
EDIT icon

Haafor (Singapore)’s Editas Medicine EDIT Stock Holding History

Haafor (Singapore)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$334K Buy
+4,761
New +$196K 0.62% 57

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Haafor (Singapore)'s EDIT Position: Q4 2020 in Review

Haafor (Singapore) opened a new position in Editas Medicine (EDIT) in Q4 2020: 4,761 shares worth $334K. The stake represents 0.62% of the portfolio and ranks #57 among its holdings.

312 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

  • Haafor (Singapore) held 4,761 shares of Editas Medicine worth $334K as of Q4 2020.
  • Editas Medicine was a new Haafor (Singapore) position in Q4 2020.
  • Editas Medicine made up 0.62% of Haafor (Singapore)'s portfolio in Q4 2020, its #57 holding.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Haafor (Singapore)'s 13F filing for Q4 2020, filed 5 Feb 2021.